did anyone see this on the email from Asthma & Lung UK?

[girl_DJ_b]

I’m intrigued by this!

[Ergendl]

That sounds exciting. And no, I hadn't noticed it.

[Swizzy]

This is probably brensocatib which has been going through trials. It is the first drug developed solely for bronch. It has proved so succesful that many who took it on the trial remained on it. I spoke to my consultant about it three weeks ago. She said that I would certainly qualify to take it. They are waiting for it to go through the processes. NICE, funding etc. So fingers crossed. If this one finally gets to us it will be the first in forty years of taking part in trials of drugs which never made it.

[girl_DJ_b in reply to Swizzy]

Wowee that’s potentially very exciting!

[Patk1 in reply to Swizzy]

Yes I imagine so,too,Swizzy.i like to check in on what he's doing.im on benrazilumab for severe eosinophilic asthma,and it has a positive impact on my bronchiectasis too

[Swizzy in reply to Patk1]

That's interesting

[Patk1 in reply to Swizzy]

Yes.brand name is Fasenra.i think it's the impact it has on inflammation that's helping bronchiectasis.trouble is it's ea 8wks but for me it wears off after 6wks,takes nr a wk to work so only getting 5wks benefit of ea 8 week cycle. its disheartening to slip backwards.but 5 wks is better than none.

[Swizzy in reply to Patk1]

Maybe the bronsicotab will work better for your bronch as brenzalizumab is really an asthma drug. Hope on the horizen.

[Alberta56]

Dr. James Chalmers talks regularly on ELF (European Lung Foundation) conferences. He sounds a lovely man. I'll post when the next conference is due, since lovely Cofdrop, who used to alert us to these events, is sadly no longer with us.

[Osha]

Very intriguing. I’ve taken note of professors name and product and will ask my consultant about it when I see him in may